Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.5355
Delayed Data
As of Aug 27
 +0.0155 / +2.98%
Today’s Change
0.50
Today|||52-Week Range
0.96
-23.50%
Year-to-Date
No recent news for Rexahn Pharmaceuticals Inc.

Today’s Trading

Previous close0.52
Today’s open0.54
Day’s range0.52 - 0.54
Volume177,642
Average volume (3 months)480,023
Market cap$94.0M
Dividend yield--
Data as of 08/27/2015

Growth & Valuation

Earnings growth (last year)-57.14%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book3.49

Competitors

 Today’s
change
Today’s
% change
CLCDCoLucid Pharmaceutic...+0.12+1.93%
ZSANZosano Pharma Corp+0.14+1.77%
XOMAXOMA Corp+0.03+3.15%
CERUCerulean Pharma Inc+0.03+0.86%
Data as of 08/27/2015

Financials

Next reporting dateNovember 12, 2015
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$0.00
Annual profit (last year)-$18.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Peter David Suzdak
Chief Financial Officer &
Secretary
Tae Heum Jeong
Corporate headquarters
Rockville, Maryland

Forecasts

Partner Offers